NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 77 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $24,191 | +110.6% | 10,338 | +164.7% | 0.00% | – |
| Q1 2024 | $11,484 | -16.4% | 3,906 | -15.0% | 0.00% | – |
| Q4 2023 | $13,745 | -3.5% | 4,597 | +2.0% | 0.00% | – |
| Q3 2023 | $14,245 | +66.0% | 4,508 | +103.3% | 0.00% | – |
| Q2 2023 | $8,580 | +65900.0% | 2,217 | -53.2% | 0.00% | – |
| Q1 2023 | $13 | +30.0% | 4,733 | -18.6% | 0.00% | – |
| Q4 2022 | $10 | -99.9% | 5,812 | -6.8% | 0.00% | – |
| Q3 2022 | $13,000 | -75.0% | 6,235 | -68.0% | 0.00% | -100.0% |
| Q2 2022 | $52,000 | +372.7% | 19,486 | +705.2% | 0.00% | – |
| Q1 2022 | $11,000 | -21.4% | 2,420 | -5.8% | 0.00% | – |
| Q4 2021 | $14,000 | +133.3% | 2,570 | +157.0% | 0.00% | – |
| Q3 2021 | $6,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 16,298,006 | $43,842,000 | 30.79% |
| Madrona Venture Group, LLC | 6,020,770 | $16,196,000 | 7.52% |
| AH Equity Partners LSV II, L.L.C. | 1,355,911 | $3,647,000 | 3.82% |
| Ally Bridge Group (NY) LLC | 1,080,566 | $2,907,000 | 2.65% |
| Tikvah Management LLC | 1,488,895 | $4,005,000 | 1.73% |
| ArchPoint Investors | 1,449,551 | $3,899,000 | 1.54% |
| Perceptive Advisors | 9,111,151 | $24,508,000 | 0.77% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $5,380,000 | 0.63% |
| CROWN ADVISORS MANAGEMENT, INC. | 250,000 | $672,000 | 0.62% |
| Affinity Asset Advisors, LLC | 466,607 | $1,255,000 | 0.53% |